• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Johnson & Johnson

Wednesday, June 05, 2024
Company Presentation
Multiple Therapeutics
Company Presentation Theater 2
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Come hear Stacy Feld share more about Johnson & Johnson’s partnering model and priority areas of interest. Learn more at https://www.jnj.com/.
Johnson & Johnson
Company Website: http://www.jnjinnovation.com
Lead Product in Development: Stelara, Darzalex, Imbruvica, Tremfya, Erleada, Xarelto

Exchange

JNJ

Ticker

JNJ

Company HQ City

New Brunswick

Company HQ State

NJ

Company HQ Country

United States

CEO/Top Company Official

Joaquin Duato

Development Phase of Primary Product

Multiple Products in Market
Primary Speaker
Stacy Feld
Regional Head
Johnson & Johnson
Back to Session List

white squarewhite

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS